Company Nutra Pharma Corp. Other OTC
Equities
NPHC
US67060U2087
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products and Technologies & Homeopathic and Ethical Drugs
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +88.32% |
Sales per region
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +88.32% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 62 | 27/16/27 | |
Rik Deitsch
PRN | Corporate Officer/Principal | 56 | 07/02/07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Rik Deitsch
PRN | Corporate Officer/Principal | 56 | 07/02/07 |
Stewart Lonky
BRD | Director/Board Member | 75 | 05/04/05 |
Garry Pottruck
BRD | Director/Board Member | 65 | 29/09/29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 12,000,000 | 0 | 0 | 100.00 % |
Stock B | 1 | 7,596,852,214 | 7,596,852,214 ( 100.00 %) | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+50.30% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |